Tobacco Control Research Branch (TCRB)
The Tobacco Control Research Branch (TCRB) leads and collaborates on research and disseminates evidence-based findings to prevent, treat, and control tobacco use in order to create a world free of tobacco use and related cancer and suffering. TCRB is within the National Cancer Institute’s (NCI) Behavioral Research Program (BRP), in the Division of Cancer Control and Population Sciences (DCCPS).
- Advertising and marketing of tobacco products
- Epidemiology and surveillance of tobacco knowledge, attitudes, and behavior
- Etiology, predictors, correlates, and determinants of tobacco use, nicotine dependence, and cessation
- Global tobacco control, especially in low- and middle-income countries
- Media and policy to reduce tobacco use
- Other tobacco products, e.g., smokeless tobacco, cigars, roll-your-own, hookah, bidis, etc.
- Potential Reduced-Exposure Tobacco Products (PREPs)
- Secondhand smoke
- Tobacco cessation interventions at the individual, system, and population levels
- Tobacco control interventions for underserved and at-risk populations
- Tobacco industry documents
- Tobacco prevention interventions at the individual, system, and population levels
- Tobacco product analysis, e.g., design and composition, constituents and additives, processing, manufacturing
- Tobacco use and cessation in cancer screening, diagnosis, treatment, and survivorship
- Tobacco-related disparities
News and Highlights
- 2018-2019 TUS-CPS dataset now available
- 2018-2019 TUS-CPS Data Brief now available (PDF, 1.5 MB)
- Smoking Cessation: A Report of the Surgeon General – Key Findings
- Tobacco Product Use and Cessation Indicators Among Adults — United States, 2018
- Cessation Research Fact Sheet (PDF, 558 KB)
- Vaping Pods Produce High Nicotine Levels in Young Users, Cancer Currents blog post
Featured Funding Announcement
- Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional/R21 Clinical Trial Optional): PAR-18-023 and PAR-18-022
- Tobacco Cessation Interventions Among People Living with HIV/AIDS (R01 Clinical Trial Optional/R21 Clinical Trial Optional): RFA-CA-18-027 and RFA-CA-18-028See More Announcements
Initiatives and Measures
TCRB Grant Portfolio and Funding Opportunities
After growing up in rural Kentucky, I moved to California and was struck by the stark geographic disparity in tobacco control policies, and became passionate about closing the gap in rural, southern states.”Amanda Fallin-Bennett, Ph.D., R.N. Other TCRB Featured Grantees
Practicing mindfulness has made a real difference in my life. Unfortunately, most of the research on mindfulness has not included very diverse populations, and I am committed to making mindfulness training more widely available to people from all walks of life. Using mobile technology could be one way to provide mindfulness training to low-income smokers who are interested in quitting smoking.”Claire Spears, Ph.D. Other TCRB Featured Grantees
As a college student I remember being moved and inspired by the new, innovative and hard-hitting visuals and messages from the first wave of the national anti-smoking "Truth" campaign - I knew then that public health and tobacco control was something I wanted to focus on and be a part of.”Olivia Wackowski, Ph.D., M.P.H. Other TCRB Featured Grantees
Read peer-reviewed manuscripts, funding analyses, and reports on behavioral research issues in cancer prevention and control.
Learn about TCRB’s organizational structure and team members. See selected funding opportunities.
Information & Resources
Learn about TCRB’s latest initiatives and tools for researchers, patients, and more.
Meet Our Staff
Our team of accomplished scientists and research associates, fellows, and administrators is dedicated to advancing behavioral science research in cancer prevention and control.TCRB Staff